|
|
ORIGINAL ARTICLE |
|
|
|
| Year : 2007 | Volume
: 23
| Issue : 1 | Page : 18-22 |
| |
Open nephron-sparing surgery in renal tumors with normal contralateral kidney: A single centre experience of 8 years
NP Gupta, A Kumar, AK Hemal, PN Dogra, A Seth, R Kumar
Department of Urology, All India Institute of Medical Sciences, New Delhi, India
Correspondence Address:
N P Gupta
Department of Urology, All India Institute of Medical Sciences, New Delhi - 110 029
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0970-1591.30259
 Abstract | | |
Introduction: We present our eight-year experience with open nephron-sparing surgery (NSS) in renal tumors with contralateral normal kidney to assess its oncological efficacy and safety. Materials and Methods: Thirty-six patients undergoing open NSS for small localized renal tumors with normal contralateral kidney from January 1998 to August 2006 were studied regarding demographic, clinical and pathological characteristics along with long-term follow-up. Results: The mean age was 48.28 ± 9.5 years. The mean tumor size was 3.72 cm (range 1.5-6). The following surgeries were performed: Wedge resection-13, partial polar nephrectomy-15, segmental resection-eight. The following techniques were used for vascular control: clamping and cooling-eight, warm ischemia-12, a novel technique of serial encirclage-16. The mean warm ischemia time was 23.2 ± 3.2 min. The mean operating time was 190.07 ± 11.3 min. The mean estimated blood loss was 331 ± 17.4 ml. The majority of renal tumors were renal cell carcinoma (97.22%). There were no positive surgical margins. There were no major intraoperative and postoperative complications. The mean follow up was 52.1 months (range 4-80) with no case showing progression to renal insufficiency (defined as serum creatinine > 2 mg/dl). There was only one local recurrence. However, four distant metastases were reported. The five-year cancer-specific survival, recurrence-free survival and overall survival were 94.4%, 88.88% and 86.11% respectively. Conclusions : In patients with solitary, small localized, unilateral renal tumors with normal contralateral kidney, elective open NSS is feasible, safe and provides excellent long-term local control and oncological efficacy with functional benefits.
Keywords: Nephron sparing surgery, open surgery, renal tumor
How to cite this article:
Gupta N P, Kumar A, Hemal A K, Dogra P N, Seth A, Kumar R. Open nephron-sparing surgery in renal tumors with normal contralateral kidney: A single centre experience of 8 years. Indian J Urol 2007;23:18-22 |
How to cite this URL:
Gupta N P, Kumar A, Hemal A K, Dogra P N, Seth A, Kumar R. Open nephron-sparing surgery in renal tumors with normal contralateral kidney: A single centre experience of 8 years. Indian J Urol [serial online] 2007 [cited 2023 May 31];23:18-22. Available from: https://www.indianjurol.com/text.asp?2007/23/1/18/30259 |
Radical nephrectomy (RN) has been considered the standard treatment for localized renal tumors with an anatomically and functionally normal contralateral kidney. The first nephron-sparing surgery (NSS) for a renal tumor was done by Czerny in 1887.[1] The initial indications of NSS for renal tumors were either absolute including a solitary kidney and bilateral renal tumors or relative, which include impending or existing renal failure.[2] Since then, interest in NSS has been growing in localized renal tumors with normal contralateral kidney due to several developments including advances in renal imaging, improved surgical techniques and methods to prevent ischemic renal injury, increasing number of incidentally detected small tumors due to better imaging and reduced complications due to better postoperative care including renal replacement therapy.[3] The various series have proved that NSS is safe, cost-effective and results in low morbidity.[4],[5] Moreover, NSS has shown effective local control and comparable five-year cancer-specific survival rate for localized renal tumors with normal contralateral kidney, equivalent to radical nephrectomy.[6] Therefore, NSS is being increasingly used in these patients.[2],[7] We present our eight-year experience with open NSS in small, localized, renal tumors with contralateral normal kidney to assess its feasibility, efficacy and long-term oncological efficacy in these patients.
| Materials and Methods | |  |
This prospective study included a total of 36 consecutive patients undergoing elective open NSS for small, localized renal tumors (clinical stage, T1N0M0) with normal contralateral kidney between January 1998 and August 2006 in our institution. The patients with large or extensive tumors, suspected lymph node involvement, advanced age and significant illness were excluded from study. All patients underwent a detailed history, physical examination, a laboratory evaluation including serum creatinine, liver function tests and urine analysis. Radiographic testing was used to exclude locally advanced or metastatic disease including chest X-ray, ultrasound abdomen, contrast enhanced computed tomography (CECT)/ magnetic resonant imaging (MRI) abdomen.
Surgical technique
The kidney was exposed using an extraperitoneal, extrapleural flank incision through the 11th or 12th rib bed. The kidney was mobilized within the Gerota's fascia leaving intact peri-renal fat around the tumor. The renal pedicle was dissected en-block and a vascular tape was encircled and kept ready for vascular clamping in selected cases. The patient was adequately hydrated and intravenous mannitol was given before arterial clamping and readministered after the vascular clamp was removed to promote brisk diuresis. When the anticipated time of arterial occlusion was more than 30 min, in situ renal hypothermia was used using peri-renal ice slush, to minimize ischemic injury to the kidney. Surgical hypothermia was established immediately after renal artery clamping and maintained for 10 min to decrease the core temperature before starting tumor resection. In 16 patients, we used a technique of serial encircling haemostatic sutures through the renal parenchyma proximal to the level of partial nephrectomy for renal cell carcinoma (RCC) to avoid cross clamping of the renal artery for polar lesions (unpublished data). We performed polar (apical, basilar) segmental nephrectomy, transverse and wedge resection, trying to remove at least 5 mm of normal tissue around the tumor, based on intraoperative palpation. In cases in which tumor was in close proximity to the pelvi-calyceal system, based on preoperative imaging study and there was anticipation of breech in the pelvi-calyceal system, methylene blue was instilled through a preplaced ureteric catheter to visualize breech of collecting system. This breech was then closed by absorbable sutures. We did not use intraoperative frozen section from tumor margin and intraoperative ultrasound. The renal defect was closed using approximating vicryl® sutures over a bolster made of Gelfoam®/ Surgicel®/muscle.
The demographic, intraoperative and postoperative outcomes, pathological characteristics and follow-up were prospectively recorded. The patients were followed with an annual history, physical examination, measurement of serum calcium, alkaline phosphatase, liver and renal function tests. The ultrasound abdomen was performed at three months postoperatively and subsequently six-monthly for two years and then yearly thereafter, using CECT abdomen in case of abnormal ultrasound findings. The five-year overall survival, cancer-specific survival and recurrence-free survival were calculated using the Kaplan Meier method. The results were then analyzed statistically and presented as the mean value ± standard deviation.
| Results | | |
The demographic profile of the patients and tumor size are detailed in [Table - 1]. 47.2% patients were detected as incidental renal masses. The mean tumor size was 3.72 cm (range: 1.5-6 cm). [Table - 2] summarizes the intraoperative and postoperative outcome. The novel technique of serial encircling sutures was used in 16 patients. The mean cold ischemia time, warm ischemia time and mean estimated blood loss were 37.1 ± 4.1 min (range: 31-47), 23.2 ± 3.2 min (range: 20-29) and 331 ± 17.4 ml respectively. There were no significant intraoperative complications except bleeding in three patients, which was controlled without any sequelae. The postoperative complications were also not significant, with no case reported of wound hernia.
[Table - 3] summarizes the pathological and follow-up results. The majority (97.22%) of renal tumors were RCC and the clear cell was the predominant subtype of RCC (77.1%). There were no positive margins in any case. The majority of patients were in pT 1a N 0 M0 (94.44%), having predominantly Grade 2 (41.6%).
The mean follow-up was 52.1 months (range: 4-80). Twenty-five (69.4%), 21 (58.3%) and 11 (30.5%) patients completed the follow-up of 36 months, 52.1 months and 60 months respectively. There was no case showing progression to renal insufficiency (defined as serum creatinine > 2 mg/dl). There was only one local recurrence in the ipsilateral kidney reported at 13 months of follow-up. This patient had a central tumor of 3.9 cm in the right kidney. There was no tumor spillage during the surgery. The histological report showed renal cell carcinoma (papillary), Grade 3 with negative margins. The patient underwent open right radical nephrectomy. The same patient developed lung metastases six months after surgery, highlighting the aggressive nature of the tumor.
There were four distant metastases (lung - three, bone - one) reported at follow-up of 13, 17, 19 and 26 months respectively. The number of events is too small to carry out multivariate analysis of various risk factors responsible for metastases. The tumor size in these patients was 6 cm, 5.2 cm, 3.9 cm and 4cm respectively. The tumors were centrally located in all patients. The histological types were RCC (clear cell with sarcomatoid differentiation), RCC (papillary), RCC (papillary) and RCC (clear cell with sarcomatoid differentiation) respectively. The histological grades were 4, 3, 3 and 4 respectively. One patient with lung metastasis and the other with bone metastasis died nine and 11 months after detection of metastases. There were three noncancer-related deaths (myocardial infarction - two, stroke - one). The five-year cancer-specific survival, recurrence- free survival and overall survival were 94.44, 88.88 and 86.11% respectively. Kaplan Meier survival curves for overall survival and recurrence-free survival are shown in [Figure - 1][Figure - 2] respectively.
| Discussion | | |
After its introduction by Czerny[1] in 1887, NSS has evolved as a surgical option for localized renal tumors. The initial indications for NSS included patients with either an absolute indication like a solitary kidney, bilateral tumors or a relative indication like when the contralateral kidney is affected by a condition that threatens its future function.[3] Nephron-sparing surgery has been increasingly used in patients with small localized renal tumors (pT 1a N 0 M 0 , size less than 4 cm) with normal contralateral kidney.[2],[7],[8],[9] There is an expansion of the indications of use of NSS to pT 1b N 0 M 0 (size less than 7 cm) recently.[10],[11] This can be explained on the basis that various reports have shown comparable local control and five-year cure rates of NSS, when compared with radical nephrectomy,[6] along with significant decrease in intraoperative and postoperative morbidity.[10],[12]
The improved surgical techniques including better methods of hemostasis, preventing ischemic renal damage and meticulous dissection have significantly decreased intraoperative and postoperative complications. One of the major concerns during NSS is adequate hemostasis of the resected surface because various reports have shown intraoperative and delayed bleeding with secondary nephrectomy as its complications.[12],[13] Various hemostatic methods like coronal sutures, fibrin glue, harmonic scalpel, lasers, electric current, dissecting clamp and a linear stapling device have been reported in the literature.[14] We have used various techniques of hemostasis including a simple, reliable and novel technique of serial encircling sutures (16 patients) wherever feasible, which avoids hilar clamping, thus causing no ischemic renal damage. This technique is inexpensive and can be easily practiced by all urologists (unpublished data). In our series, intraoperative (8.3%) and postoperative (2.7%) bleeding are comparable with other series.[12],[13] Our mean warm ischemia time of 23.2 min is also comparable with other series (Gill et al [15] - 17.5 min, Ray et al [16] - 20 min).
The most common renal-related complications after NSS is urinary fistula, occurring in 6.5% patients (range - 1.4- 17.4).[13] In our series, there was no case of urinary fistula. This can be attributed to our technique of using methylene blue injection through a preplaced ureteric catheter while excising tumor and subsequently, closing any defect in the collecting system intraoperatively, with absorbable sutures.
Another major concern with this approach has been the risk of local recurrence due to inadequate tumor excision or tumor multifocality, thus decreasing long-term survival. However, various studies have proved convincingly the long-term oncological efficacy of NSS in terms of local recurrence and five-year cure rates.[7],[17],[18] The local recurrence and five-year cancer-specific survival has been reported to be 0-7.3% and 89-98% respectively, in different series.[7],[8],[9],[13],[17] In our series, there were no positive margins. After a mean follow-up of 52.1 months (range: 4-80), there was only one local recurrence (2.7%). The high grade of the tumor and the possibility of undetected microscopic multifocal renal cell carcinoma, in view of papillary histology, can cause the local recurrence in this case. The five-year cancer-specific survival was 94.4%, thus comparable with other reported series. There were only four cases (11.1%) of distant metastases at 13, 17, 19 and 26 months respectively: lung - three, bone - one. There were only two (5.55%) cancer-related deaths and three (8.33%) noncancer-related deaths.
There are some definitive advantages of NSS in patients with normal contralateral kidneys. Firstly, there is a speculation that the advantage of maximal nephron preservation might decrease the risk of progression to chronic renal insufficiency and end stage renal disease. The recent studies by Lau et al[18] and McKiernan et al[19] have shown that RN resulted in higher cases of renal insufficiency (defined as increase in serum creatinine > 20 mg/L), when compared with NSS. In our series, no case showed progression to renal insufficiency (defined as increase in serum creatinine > 20 mg/dl) at a mean follow-up of 52.1 months, thus proving the functional benefits of NSS. Secondly, synchronous or metachronous bilateral involvement has been reported in 2-4% cases of sporadic RCC.[20] Therefore, in a patient of RCC with normal contralateral kidney, there is a possibility of involvement of the contralateral normal kidney in future by RCC. Therefore, we can preserve the maximum functional renal parenchyma in these patients by doing a nephron-sparing surgery.
| Conclusions | | |
In patients with solitary, small localized, unilateral renal tumors with normal contralateral kidney, elective open NSS is an appropriate, safe and feasible surgical option, which provides excellent long-term oncological results with functional benefits.
| References | | |
| 1. | Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thuroff JW. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol 2006;175:2027-31.  [PUBMED] [FULLTEXT] |
| 2. | Czerny HE. Cited by Herczel E. Uber nierenextirpation. Beitr 2 Klin Chir 1890;6:485. |
| 3. | Novick AC, Derweesh I. Open partial nephrectomy for renal tumors: Current status. BJU Int 2005;95:35-40. [PUBMED] |
| 4. | Stephenson AJ, Hakimi AA, Snyder ME, Russo P. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol 2004;171:130-4. [PUBMED] |
| 5. | Novick AC. Nephron sparing surgery for renal cell carcinoma. BJU Int 1998;82:321-4. [PUBMED] |
| 6. | Lerner SE, Hawkins CA, Blute ML , Grabner A, Wollan PC, Eickholt JT, et al . Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 2002;167:884-90. |
| 7. | Herr HW. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10 year follow up. J Urol 1999;161:33-5. [PUBMED] |
| 8. | Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: Impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999;162:1930-3. [PUBMED] |
| 9. | Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 2000;163:730-6. [PUBMED] |
| 10. | Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, et al . Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicentre experience. J Urol 2004;171:2181-5. |
| 11. | Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 2004;171:1066-70. [PUBMED] |
| 12. | Thompson RH, Leibovich BC, Lohse CM, Zincke H, Blute ML. Complications of contemporary open nephron sparing surgery: A single institution experience. J Urol 2005;174:855-8. [PUBMED] |
| 13. | Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: Indications, techniques and outcomes. J Urol 2001;166:6-18. [PUBMED] |
| 14. | Tsivian A, Sidi AA. A simple and reliable hemostatic technique during partial nephrectomy. Urology 2004;63:976-8. [PUBMED] [FULLTEXT] |
| 15. | Gill IS, Matin SF, Desai MM, Kaouk JH, Steinberg A, Mascha E, et al . Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol 2003;170:64-8. |
| 16. | Ray ER, Turney BW, Singh R, Chandra A, Cranston DW, O'Brien TS. Open partial nephrectomy: Outcomes from two UK centres. BJU Int 2006;97:1211-5. [PUBMED] [FULLTEXT] |
| 17. | Zigeuner R, Quehenberger F, Pummer K, Petritsch P, Hubmer G. Long term results of nephron sparing surgery for renal cell carcinoma in 114 patients: Risk factors for progressive disease. BJU Int 2003;92:567-71. [PUBMED] [FULLTEXT] |
| 18. | Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000;75:1236-42. [PUBMED] |
| 19. | McKiernan J, Simmons R, Katz J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002;59:816-20. [PUBMED] [FULLTEXT] |
| 20. | Farrow GM. Diseases of the kidney. In : Murphy WM, editor. Urological Pathology, 2nd ed. WB Saunders: Philadelphia; 1997. p. 464-70. |
[Figure - 1], [Figure - 2]
[Table - 1], [Table - 2], [Table - 3]
| This article has been cited by | | 1 |
COMPARISON OF INCIDENTALLY DETECTED RCC VS SYMPTOMATIC: A SINGLE CENTER EXPERIENCE. |
|
| Ishwar Ram Dhayal | | INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. 2022; : 5 | | [Pubmed] | [DOI] | | | 2 |
Nephron-sparing surgery for renal tumors |
|
| Abd El Hamid H. Ezzat, Ahmed Helmy, Ashraf H. Ibrahim | | Journal of the Egyptian National Cancer Institute. 2011; | | [VIEW] | [DOI] | | | 3 |
Evaluation of nephron sparing surgery for renal tumors: a single institution experience |
|
| Hytham Abd-elkareem Ahmed, Abdelhamid Hussein Ezzat, Ismael Mourad | | The Chinese-German Journal of Clinical Oncology. 2011; 10(9): 517 | | [VIEW] | [DOI] | | | 4 |
Open partial nephrectomy with no clamping of the pedicule: A good surgical option in treatment of renal cancer |
|
| Dente, D., Paniccia, T., Petrone, D., Gaspari, G., Tucci, C., Rossetti, R., Pompa, P. | | Minerva Urologica e Nefrologica. 2010; 62(4): 341-346 | | [Pubmed] | | | 5 |
Renal tumors presentation: Changing trends over two decades |
|
| Gupta, N.P. and Ishwar, R. and Kumar, A. and Dogra, P. and Seth, A. | | Indian Journal of Cancer. 2010; 47(3): 287-291 | | [Pubmed] | | | 6 |
Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience |
|
| Sophia Mylona,Anna Kokkinaki,Maria Pomoni,Panagiota Galani,Sparti Ntai,Loukas Thanos | | European Journal of Radiology. 2009; 69(2): 351 | | [Pubmed] | [DOI] | | | 7 |
Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience |
|
| Show Abstract Mylona, S., Kokkinaki, A., Pomoni, M., Galani, P., Ntai, S., Thanos, L. | | European Journal of Radiology. 2009; 69(2): 351-356 | | [Pubmed] | |
|
|
|
|
|
|
|
|
